Microsoft (MSFT) rises Thursday evening on Q4 earnings beat >>> READ MORE

Flu Season Is Coming — And These Companies Are Ready

As folks get the flu, several publicly traded companies benefit

      View All  


Doctor ChartNot everyone can battle the flu with some over-the-counter meds and comfort foods. Folks who are really sick and high-risk individuals like the young and elderly will probably need some professional care.

That’s where healthcare providers such as Aetna (AET) or Cigna (CI) come in. They can help you out with a quick doctor’s visit.

And once you’re in doc’s office, there’s a pretty good chance that you’ll get prescribed Tamiflu or Relenza — unless we get the CDC up and running, and it decides antiviral drugs won’t do the trick. The former is owned by Roche’s (RHHBY) Genentech, while GlaxoSmithKline is responsible for the latter.

Tamiflu is notable, especially for the H3N2 strain that was prevalent last flu season, because it’s the only product approved to treat flu infection in children younger than 1.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC